← Back to patent-cliff list
Orenetide
Tier C — Watch / tradeOrenetide
Ivix
Originator
2022
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Desirix
Indications (approved)：Psychogenic sexual dysfunction
Regional status
US
-
EU
Approved
2022-02-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Orenetide?
Approved indications include: Psychogenic sexual dysfunction.
When does the Orenetide patent expire?
No public expiry year is available for Orenetide yet; this page updates once verified.
How do I get a quote for Orenetide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27